Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 May;37(5):1122–1126. doi: 10.1128/aac.37.5.1122

Activity of pirlimycin against pathogens from cows with mastitis and recommendations for disk diffusion tests.

C Thornsberry 1, J K Marler 1, J L Watts 1, R J Yancey Jr 1
PMCID: PMC187914  PMID: 8517701

Abstract

Pirlimycin is an analog of clindamycin that will be recommended for therapy of bovine mastitis. It has good activity against staphylococci and streptococci, the major pathogens for bovine mastitis. Five hundred and thirty bacterial isolates recovered from cows with mastitis were studied to confirm the spectrum of activity and to develop recommendations for susceptibility testing. Pirlimycin is not active against isolates of Enterobacteriaceae, it varies in its activity against enterococci, and it is active against veterinary isolates of streptococci (MIC for 50% of strains tested, < or = 0.03 to 0.06 microgram/ml) and staphylococci (MIC for 50% of strains tested, 0.25 to 1.0 microgram/ml). On the basis of levels of drug attained in the milk with recommended dosing schedules, we chose MIC breakpoints of < or = 2 micrograms/ml for susceptibility and > or = 4 micrograms/ml for resistance. We also recommended a disk diffusion test using a disk containing 2 micrograms/ml and breakpoints of < or = 12 mm for resistance and > or = 13 mm for susceptibility.

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkenmeyer R. D., Kroll S. J., Lewis C., Stern K. F., Zurenko G. E. Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent. J Med Chem. 1984 Feb;27(2):216–223. doi: 10.1021/jm00368a020. [DOI] [PubMed] [Google Scholar]
  2. Metzler C. M., DeHaan R. M. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis. 1974 Dec;130(6):588–594. doi: 10.1093/infdis/130.6.588. [DOI] [PubMed] [Google Scholar]
  3. Owens W. E., Watts J. L. Effects of milk on activity of antimicrobics against Staphylococcus aureus isolated from bovine udders. J Dairy Sci. 1987 Sep;70(9):1946–1951. doi: 10.3168/jds.S0022-0302(87)80236-9. [DOI] [PubMed] [Google Scholar]
  4. Thornsberry C., McDougal L. K. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol. 1983 Nov;18(5):1084–1091. doi: 10.1128/jcm.18.5.1084-1091.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Watts J. L. Etiological agents of bovine mastitis. Vet Microbiol. 1988 Jan;16(1):41–66. doi: 10.1016/0378-1135(88)90126-5. [DOI] [PubMed] [Google Scholar]
  6. Yancey R. J., Jr, Kinney M. L., Ford C. W. Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice. J Antimicrob Chemother. 1985 Feb;15(2):219–232. doi: 10.1093/jac/15.2.219. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES